Steps toward therapeutically targeting the activin type II receptor for treating heart failure
Am J Physiol Heart Circ Physiol
.
2020 Feb 1;318(2):H326-H328.
doi: 10.1152/ajpheart.00004.2020.
Epub 2020 Jan 10.
Authors
Samantha J Paddock
1
2
3
,
Caitlin C O'Meara
1
2
3
Affiliations
1
Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
2
Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
3
Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
PMID:
31922889
PMCID:
PMC7052619
DOI:
10.1152/ajpheart.00004.2020
No abstract available
Publication types
Editorial
Comment
MeSH terms
Activin Receptors
Activins
Fibrosis
Heart Failure*
Humans
Ventricular Remodeling*
Substances
Activins
Activin Receptors
Grants and funding
R01 HL141159/HL/NHLBI NIH HHS/United States
T32 HL007852/HL/NHLBI NIH HHS/United States